Current
Home > QST WebSite > Development of an α-emitter-labeled radiopharmaceutical targeting tumor cell

QST WebSite

Development of an α-emitter-labeled radiopharmaceutical targeting tumor cell

Update:2018年12月26日更新
Display printing page

Development of an α-emitter-labeled radiopharmaceutical targeting tumor cell の画像

Therapeutic efficacy of α-emitter meta-211At-astato-benzylguanidine (MABG) in a pheochromocytoma model
Yasuhiro Ohshima, Shigeki Watanabe, Atsuishi Tsuji, Kotaro Nagatsu, Tetsuya Sakashita, Akira Sugiyama, Yoshinobu Harada, Atsuo Waki, Keiichiro Yoshinaga and Noriko Ishioka ​(J. Nucl. Med., May 1, 2016, vol.57, No. supplement 2 468)